About Index Trending news
Analyze
Pricing
Nabriva Therapeutics

Nabriva Therapeutics

Nabriva Therapeutics

Nabriva Therapeutics is a biopharmaceutical company focused on the R&D of antibiotics for use in community and hospital infections.

Elsewhere

Alexa global traffic share

Latest funding
Venture capital (Series B)
$120,000,000
Employees

Unknown size

Locations
HQ
Headquarters
VentureWire

Nabriva Therapeutics Amasses $120M for Drug to Treat Bacterial Pneumonia

Health Funding